<DOC>
	<DOC>NCT00419393</DOC>
	<brief_summary>To provide continued treatment of Keppra XR (Levetiracetam XR) and to assess the long term safety of Keppra XR in subjects with partial onset seizures.</brief_summary>
	<brief_title>Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Subjects who were randomized into study N01280 [NCT00419094], and completed the 2 week up titration period Subjects who did not meet the inclusion/exclusion criteria for N01280 [NCT00419094] Subjects who were discontinued prior to the end of titration period</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Keppra XR</keyword>
	<keyword>Levetiracetam XR</keyword>
	<keyword>long term</keyword>
	<keyword>partial seizures</keyword>
</DOC>